Category: Parry
-
Isracann Biosciences (IPOT.C): The TGOD of Israel gathers a large early retail investor base
A few days ago, I published a story about our friends from HIKU/Tokyo Smoke/Doja/Saxx who, having exited from their last company with a $400m+ acquisition by Canopy Growth Corp (WEED.T), were quietly gathering investors for their next deal, Stately. That deal had closed quickly, with way more money looking to get in than they had…
-
Wildflower Brands (SUN.C) fires stock out of a cannon to be first movers in BC dispensary scene
You’ve got to hand it to Wildflower Brands (SUN.C) boss William Maclean, he’s a sucker for an opportunity. Back in the day, Wildflower’s origin story was they were going to grow weed on Vancouver Island. But the residents went all NIMBY, so he looked to Washington State. Then he locked in on vapes, then CBDs,…
-
The HIKU crowd are getting the band back together: Stately is now a thing
There’s a really important graphic in the investor presentation from the guys behind Stately, who were previously the guys behind HIKU/Tokyo Smoke, and before that were the guys behind DOJA, and before that were the guys who started the premium underwear line, Saxx. DOJA wasn’t a big play. It was a nice little facility in…
-
Sproutly (SPR.C) doubles on revelations of beverage partner negotiations/license granting
Oh, how you laughed. “Sproutly?” you exclaimed. “A cannabis beverage company? Right. Okay. Sure.” Then you chuckled as you turned your back. Who’s laughing today? Sproutly (SPRT.C) has sat churning since late November, down a half from where it opened its life on the Canadian public markets, with no amount of news about good people…
-
Cresco Labs’ (CL.C) no-premium acquisition offer of Origin House (OH.C) is… alright
This morning, Chicago-based Cresco Labs (CL.C) announced it would be acquiring Origin House (OH.C) (formerly CannaRoyalty) in an all-stock deal worth CAN$1.1 billion. The offer comes in at CAN$12.68 per Origin House share. Origin House closed Friday at $12.05, which leaves the premium on the deal being less than amazing. In fact, the stock has…
-
Cannabis Life Sciences (CSE:CLSH.U): The US multi state operator value pick
I love it when the market is busy fighting over inflated market caps, because I’m a Moneyball guy. I like value, and while a lot of money has moved toward Canadian cannabis operators in recent years, the size of the market down south is only now starting to become clear. There’s still some value floating…
-
Rift Valley Resources (RVR.C): Rural internet through TV signals? Hmm..
Sometimes bringing on a new client in my line of work can be a tricky business. Because we stand behind our much ballyhooed commitment to present you unbiased coverage on the companies we write about, whether they pay for our attention or not, we sometimes have to deal with the experience of firms that aren’t…
-
Yield Growth Corp (BOSS.C) secures hemp/oil facility, pays cash for it like a boss
In this era of companies looking to buy low value/high priced assets as expensively as possible to ensure ponzi-like market cap bumps, I can appreciate when a company finds a reasonably priced asset with real world revenues and functionality, that one can see for ones self if one takes a drive down Highway 1. I…
-
Westleaf (WL.V) brings prairie focus, first nations connections, novel ideas
I first heard about the Prairie Records cannabis retail business model mid last year. And my first thought upon seeing it was, this will never be allowed. Basically, instead of keeping everything behind glass and having consumers guess as to what weed they’re looking at and what it will do, Westleaf’s retail model is to…
-
Cannara Biotech (LOVE.C) makes MedMen look like a charitable institution
Cannara Biotech (LOVE.C) is a pig. I mean, okay. Pigs are actually kind of cool, they’re smart and bacon tastes good and they like a tummy rub, so Cannara is not actually a pig. But it is a trap for your money, and you should ideally not play with money traps because their sole purpose is,…